KIM BLUE

K262284 · Desarrollo e Investigación Médica Aragonesa S.L. · OTN · Oct 16, 2026 · General, Plastic Surgery

Device Facts

Record IDK262284
Device NameKIM BLUE
ApplicantDesarrollo e Investigación Médica Aragonesa S.L.
Product CodeOTN · General, Plastic Surgery
Decision DateOct 16, 2026
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 878.3300
Device ClassClass 2
AttributesTherapeutic

Indications for Use

KIM BLUE is a device intended to be used as a surgical mesh system for treatment of female stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency.

Device Story

KIM BLUE is a sterile, single-use surgical mesh system for treating female stress urinary incontinence. It consists of a knot-free, macroporous polypropylene mesh sling with UHMWPE traction threads and polypropylene transition cones, plus stainless steel retropubic passer instrumentation. Used by urologists, gynecologists, or urogynecologists in a hospital setting, the device is implanted transvaginally via a retropubic approach. The mesh is positioned under the mid-urethra to act as a permanent suburethral support or 'hammock,' providing resistance during increased abdominal pressure (e.g., coughing, sneezing). The passer instrumentation facilitates controlled manual placement of the sling. The device restores mid-urethral support, potentially improving patient continence.

Clinical Evidence

Bench testing only. Performance assessments included mesh thickness, weave characteristics, pore size, density, tensile strength, stiffness, suture pullout, burst strength, and tear resistance. Passer instrumentation underwent bending and tensile testing. Biocompatibility was assessed per ISO 10993-1. Sterility, packaging, and shelf-life were validated per ISO 11135, ISO 11607, and ASTM standards.

Technological Characteristics

Sling: Blue polypropylene monofilament (<0.5% Copper Phthalocyanine), UHMWPE traction threads, polypropylene transition cones. Passer: Stainless steel needle tips, stainless steel/polypropylene handle. Type I, warp-knitted, macroporous mesh (pore size >0.075 mm). Sterilization: Ethylene oxide. Single-use, permanent implant.

Indications for Use

Indicated for adult females (22+ years) with stress urinary incontinence due to urethral hypermobility and/or intrinsic sphincter deficiency.

Regulatory Classification

Identification

Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.

Predicate Devices

Submission Summary (Full Text)

{1} [LOGO] FDA U.S. FOOD & DRUG ADMINISTRATION October 16, 2026 Desarrollo e Investigación Médica Aragonesa S.L. Andrea Portaña Sanz, QA/RA Polígono Industrial Mediavega, Parcela 2.8 Calatayud, 50300 SPAIN Re: K262284 Trade/Device Name: Kim Blue Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: OTN Dated: September 16, 2026 Received: September 16, 2026 Dear Andrea Portaña Sanz: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: The Center for Devices and Radiological Health (CDRH) does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, the Food and Drug Administration (FDA) may publish further announcements concerning your device in the Federal Register. Before making any change significantly affecting the safety or effectiveness of the device, you must submit a new premarket notification in accordance with 21 CFR 807.81. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {2} K262284 - Andrea Portaña Sanz Page 2 When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See {3} K262284 - Andrea Portaña Sanz Page 3 the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, JESSICA K. NGUYEN -S Jessica K. Nguyen, Ph.D. Assistant Director DHT3B: Division of Reproductive, Gynecology, and Urology Devices OHT3: Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {4} | Indications for Use | | | | --- | --- | --- | | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K262284 | ? | | Please provide the device trade name(s). | | ? | | KIM BLUE | | | | Please provide your Indications for Use below. | | ? | | KIM BLUE is a device intended to be used as a surgical mesh system for treatment of female stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency. | | | | Please select the types of uses. | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? | | Please select the age group(s) for which the device(s) is to be used. | ☐ Neonates/Newborns (Birth to < 29 days old) ☐ Infants (29 days old to < 2 years old) ☐ Children (2 years old to < 12 years old) ☐ Adolescents (12 years old to < 22 years old) ☑ Adults (22 years old and greater) | ? | {5} K262284 Page 1 of 5 # 510(k) SUMMARY This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of 21 CFR 807.92: ## I. SUBMITTER INFORMATION **21 CFR 807.92(a)(1)** ### APPLICANT | Company Name: | Desarrollo e Investigación Médica Aragonesa S.L. | | --- | --- | | Address: | Polígono Industrial Mediavega, Parcela 2.8 | | City, State, Zip | 50300 Calatayud (Zaragoza), Spain | | Tel: | +34 976884065 | | Contact Name: | Francisco Farrer | ### CORRESPONDENT | Company Name: | Desarrollo e Investigación Médica Aragonesa S.L. | | --- | --- | | Address: | Polígono Industrial Mediavega, Parcela 2.8 | | City, State, Zip | 50300 Calatayud (Zaragoza), Spain | | Tel: | +34 976884065 | | Contact Name: | Andrea Portaña | | Date Prepared: | October 14, 2026 | ## II. DEVICE INFORMATION **21 CFR 807.92(a)(2)** | Device Trade Name: | KIM BLUE | | --- | --- | | Common/Usual Name: | mesh, surgical synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | | Classification Name: | Surgical Mesh | | Classification Number: | 21 CFR § 878.3300 | | Regulatory Class: | Class II | | Device Review Panel: | Gastroenterology-Urology Product | | Product Code: | OTN | ## III. IDENTIFICATION OF THE PREDICATE **21 CFR 807.92(a)(3)** ### Predicate Device | Predicate Manufacturer: | Desarrollo e Investigación Médica Aragonesa S.L. | | --- | --- | | Predicate Trade Name: | KIM (Knotless Incontinence Mesh) | | Predicate 510(k): | K103022 | No secondary predicate or reference device was used in this submission. The predicate has not been subject to a design-related recall. ---510(k) Summary Page 1 of 5 {6} K262284 Page 2 of 5 # IV. DESCRIPTION OF THE DEVICE 21 CFR 807.92(a)(4) KIM BLUE is a sterile, single-use surgical mesh system intended for the treatment of female stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency. The device is intended to be implanted transvaginally using a retropubic approach by qualified physicians, such as urologists, gynecologists, or urogynecologists, trained in surgical procedures for the treatment of female stress urinary incontinence. KIM BLUE consists of one sling assembly and single-use retropubic passer instrumentation used to facilitate placement of the sling. The sling assembly is a knot-free, non-coated, synthetic, macroporous mesh manufactured from blue polypropylene monofilament containing <0.5% Copper Blue colorant, with Ultra-high-molecular-weight polyethylene (UHMWPE) traction threads and polypropylene transition cones at each end. The sling is positioned under the mid-urethra, where it acts as a permanent suburethral support or "hammock" intended to provide additional urethral support during increases in abdominal pressure, such as coughing, sneezing, laughing, or physical activity. The scientific principle of the device is based on restoration of mid-urethral support in patients with stress urinary incontinence by placing a permanent polypropylene mesh sling under the urethra. The retropubic passer instrumentation consists of two single-use passer needle tips and one detachable single-use passer handle with screw, which allow controlled manual passage of the sling during implantation. KIM BLUE is provided sterile, sterilized by ethylene oxide, and is intended for single use only in a hospital or equivalent healthcare facility. # V. INDICATIONS FOR USE STATEMENT 21 CFR 807.92(a)(5) KIM BLUE is a device intended to be used as a surgical mesh system for treatment of female stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency. # INDICATIONS FOR USE COMPARISON The subject device and the predicate device (K103022) have the same indications for use. # VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE 21 CFR 807.92(a)(6) # TECHNOLOGICAL COMPARISON The subject device and the predicate device have substantially equivalent technological characteristics, as shown in the table below: | | KIM BLUE (K262284) | KIM (K103022) | SE Comparison | | --- | --- | --- | --- | | Product Code | OTN | OTN | Identical | | Manufacturer | Desarrollo e Investigacion Medica Aragonesa S.L. | Desarrollo e Investigacion Medica Aragonesa S.L. | Identical | | Indications for use | KIM BLUE is a device intended to be used as a surgical mesh system for treatment of female stress urinary incontinence resulting from urethral hypermobility and/or intrinsic sphincter deficiency. | KIM (Knotless Incontinence Mesh) is a surgical mesh kit for treatment of female stress urinary incontinence resulting from urethral hyper mobility and / or intrinsic sphincter deficiency. | Identical | | Device configuration | Single use, sterile device. | Single use, sterile device. | Identical | 510(k) Summary Page 2 of 5 {7} K262284 Page 3 of 5 | Target structures | | The mesh sling is in contact with the vaginal submucosa tissue of the mid-urethra. | The mesh sling is in contact with the vaginal submucosa tissue of the mid-urethra. | Identical | | --- | --- | --- | --- | --- | | Clinical mechanism to achieve continence | | Mid-urethral support. | Mid-urethral support. | Identical | | Placement | | Retropubic | Transobturator | Different | | Use of Anesthesia | | Regional or general anesthesia | Regional or general anesthesia | Identical | | Materials | Sling Mesh | Blue polypropylene monofilament with <0.5% Copper Phthalocyanine blue colorant | Clear polypropylene monofilament and blue polypropylene monofilament with <0.5% Copper Phthalocyanine blue colorant | Different | | | Sling Traction Threads | UHMWPE | UHMWPE | Identical | | | Sling Transition Cones | Polypropylene | POM (Polyoxymethylene) | Different | | | Passer Needle Tip | Stainless Steel | Stainless Steel | Identical | | | Passer Handle and Screw | Stainless Steel & Polypropylene | Polypropylene | Different | | Reuse | Sling | Single use | Single use | Identical | | | Passers | Single use | Single use | Identical | | Permanent implant components | | Mesh | Mesh | Identical | | Sterilization agent / Method | | Ethylene Oxide | Ethylene Oxide | Identical | | Mesh filament structure | | Monofilament | Monofilament | Identical | | Mesh structure | | Warp Knitted | Warp Knitted | Identical | | Amid Type | | Type I | Type I | Identical | | Mesh characteristics | Weave Characteristics | Warp knitted | Warp knitted | Identical | | | Pore size | >0.075 mm | >0.075 mm | Identical | | Sling-Passers connection | | Place the Traction Thread at the end of the Sling through the grooves in the proximal tips of the Passer Needles, to drive the Sling to the end incisions. | Place the Traction Thread at the end of the Sling through the grooves in the proximal tips of the Passer Needles, to drive the Sling to the end incisions. | Identical | The subject device, KIM BLUE, and the predicate device have the same intended use and the same fundamental technological principle of operation. Both are sterile, single-use, synthetic, non-absorbable, non-coated, macroporous polymeric mid-urethral sling systems intended to provide permanent suburethral support for the treatment of female stress urinary incontinence. The devices have comparable overall design, mode of action, anatomical target, function of the implant, and sterilization method. In both devices, the permanent implantable component is positioned to function as a supportive sling under the mid-urethra. Both systems also include ancillary/deployment components intended to facilitate sling placement during the surgical procedure. 510(k) Summary Page 3 of 5 {8} K262284 Page 4 of 5 The identified differences are limited to certain material and accessory-related differences. The sling material differences have been addressed through the biological evaluation of the subject device, including biocompatibility assessment and supporting chemical characterization/toxicological risk assessment, as applicable. The passer handle material difference is limited to a non-patient-contacting ancillary component. These differences do not affect the intended use, principle of operation, anatomical target, or performance of the implanted sling. ### VIII. BRIEF DISCUSSION OF NONCLINICAL TESTS 21 CFR 807.92(b)(1) The following nonclinical testing was conducted to support the substantial equivalence determination. #### Biocompatibility Testing KIM Blue biocompatibility has been assessed through literature review and testing according to the requirements of the ISO 10993-1:2018: Biological evaluation of medical devices, Part 1: Evaluation and testing within a risk management process, and 2023 FDA guidance document titled “Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process.” Based on the nature of use and duration of exposure: - the passer needle tip is categorized as an externally communicating device with limited, tissue contact in patients (< 24 hrs); - the transition cones and traction threads are categorized as limited contact device with tissues in patients (< 24 hrs); - the sling mesh is categorized as a long-term implant with tissue contact in patients (> 30 days). #### Sterilization Validation KIM Blue is sterilized using ethylene oxide in a validated cycle, demonstrating a sterility assurance level (SAL) of 10⁻⁶. Sterilization validation was completed per ISO 11135:2014 Sterilization of health-care products — Ethylene oxide — Requirements for the development, validation and routine control of a sterilization process for medical devices and summarized in accordance with the 2024 FDA Guidance "Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile." Bacterial endotoxin test (BET) was used to demonstrate KIM BLUE met pyrogen limit specifications. #### Packaging and Shelf-life Packaging and shelf-life evaluations were performed to support the maintenance of sterile barrier integrity and device performance throughout the proposed shelf life. The results support that the device packaging maintains sterility and that the device continues to meet applicable specifications over the claimed shelf life. The following standards were used to support the claimed shelf life: - ASTM F1980-21: Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices - ISO 11607-1:2019: Packaging for terminally sterilized medical devices Part 1: Requirements for materials, sterile barrier systems and packaging systems - ASTM D4169-22: Standard Practice for Performance Testing of Shipping Containers and Systems #### Performance Testing (non-clinical benchtop): In accordance with the FDA’s “Guidance for the Preparation of a Premarket Notification Application for Surgical Mesh”, the following mesh characteristics were assessed: mesh thickness, mesh weave characteristics, pore size, mesh density, tensile strength, mesh stiffness, suture pullout 510(k) Summary Page 4 of 5 {9} K262284 Page 5 of 5 strength, burst strength, and tear resistance. Additionally, the following tests were conducted on the device: Passer-Needle bending test, Passer-Needle disassembly tensile test, Sling Traction Thread tensile strength at break and Sling mesh porosity test. Results of performance testing demonstrate equivalent device function based on the intended use of the device when compared to that of the predicate device. ## IX. CONCLUSION **21 CFR 807.92(b)(3)** The subject device, KIM BLUE, has the same indications for use when compared with the predicate device, KIM (Knotless Incontinence Mesh) (K103022). The subject device and the predicate have similar technological characteristics. Based on the comparison of technological characteristics and the supporting data provided in this submission, the identified differences do not raise different questions of safety or effectiveness compared to the predicate device. Non-clinical testing shows that the subject device is as safe and effectiveness as the predicate device and is substantially equivalent to the predicate device. ---510(k) Summary Page 5 of 5
Innolitics
Guidance Recalls

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...